Home › Follicular Lymphoma › Wisconsin › Milwaukee
Pag-aaral pangklinika para sa Follicular Lymphoma sa Milwaukee, WI
19 pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Milwaukee (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi ang layo
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi ang layo
- at 3 pa
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Vivent Health, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Nagre-recruitPhase 3
- Research Site, Milwaukee
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Nagre-recruitPhase 2
- Research Site, Milwaukee
A Study of ARC-02 in B-cell NHL
Nagre-recruitPhase 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
- Medical College of Wisconsin, Milwaukee
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Nagre-recruitPhase 3
- Prohealth Care Inc, Waukesha · 17 mi ang layo
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Nagre-recruitPhase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- Medical College of Wisconsin, Milwaukee
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Nagre-recruitPhase 2
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Nagre-recruitPhase 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- Medical College of Wisconsin, Milwaukee
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- The Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Nagre-recruitObservasyonal na pag-aaral
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Milwaukee
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Nagre-recruitObservasyonal na pag-aaral
- CIBMTR, Milwaukee
Pag-aaral para sa Follicular Lymphoma sa ibang lungsod
- New York City, NY24 pag-aaral
- Nashville, TN18 pag-aaral
- Houston, TX18 pag-aaral
- Boston, MA17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Seattle, WA15 pag-aaral
- Durham, NC15 pag-aaral
- Salt Lake City, UT13 pag-aaral
- Columbus, OH13 pag-aaral
- Chicago, IL12 pag-aaral
- San Antonio, TX12 pag-aaral
- Philadelphia, PA12 pag-aaral
Iba pang pag-aaral sa Milwaukee
- Kanser sa Suso23 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Non-Small Cell Lung Cancer22 pag-aaral
- Multiple Myeloma21 pag-aaral
- Kanser sa Baga21 pag-aaral
- Kanser sa Prostate20 pag-aaral
- Non-Hodgkin Lymphoma18 pag-aaral
- Kanser sa Pancreas18 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Diffuse Large B-Cell Lymphoma16 pag-aaral
- Burkitt Lymphoma16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.